CClinicalTrials.gg
CompletedNCT00916331Updated Jun 9, 2009

Subcutaneous Indwelling of Vacuum Drainage in Total Knee Arthroplasty

A Phase 4 interventional study of subcutaneous indwelling and intraarticular indwelling in Total Knee Arthroplasty, sponsored by Seoul National University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 54 Years to 85 Years. Per ClinicalTrials.gov, last updated 2009-06-09.

Sponsored by Seoul National University Hospital · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
111
Allocation
Randomized
Ages
54 Years to 85 Years
Sex
All
01

Study summary

This prospective, randomized trial asked whether subcutaneous indwelling of vacuum drainage has advantages over intraarticular indwelling in terms of blood loss, bleeding related complications, and functional outcomes in primary total knee arthroplasty (TKA). The investigators hypothesized that the subcutaneous indwelling method would reduce blood loss with comparable bleeding-related complications and functional outcomes. The subcutaneous indwelling group demonstrated reduced blood loss with comparable prevalence of bleeding-related complications and functional outcomes. In conclusion, the investigators' study verified the efficacy and absence of risks of subcutaneous indwelling method. So the investigators propose that the subcutaneous indwelling drainage can be a good option to address the problems related to postoperative bleeding after TKA.

Read the detailed description

There are numerous reports in the literature on drainage options after TKA, but there is no consensus. Many studies have shown no apparent advantage of drainage but routine intraarticular indwelling drainage after TKA has been extensively used to avoid complications associated with hematoma formation. It is of interest to determine if it is possible to reduce blood loss while still using drainage. So we came to think about a new and more convenient method-subcutaneous indwelling. Theoretically subcutaneous indwelling method which still has the advantages over the intraarticular indwelling method but is more convenient than drain-clamping method may be a better option. So we hypothesized that subcutaneous indwelling method of vacuum drainage has advantages over the intraarticular indwelling method.

02

Conditions studied

  • Total Knee Arthroplasty

Keywords

  • total knee replacement arthroplasty
  • subcutaneous indwelling
  • blood loss
  • complications
  • functional status
03

In context

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,859 studies on the registry; 274 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
54 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosis of primary osteoarthritis
  • primary total knee arthroplasty
  • Signed written informed consent
  • Spinal/epidural anesthesia

Exclusion criteria

Exclusion Criteria:

  • Patients with coagulation disorders
  • Revision total knee arthroplasty
  • Simultaneous bilateral total knee arthroplasty
  • Diagnosis other than primary osteoarthritis
  • Patients refusing consents
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
111 participants (actual)

Study arms

  • Experimental
    subcutaneous group

    Vacuum drainage is indwelled in subcutaneous layer

    Procedure: subcutaneous indwelling

  • Experimental
    intraarticular group

    Vacuum drainage is indwelled in intraarticular space

    Procedure: intraarticular indwelling

Interventions

  • Proceduresubcutaneous indwelling

    vacuum drainage is indwelled in subcutaneous layer

    Also known as: hemovac

  • Procedureintraarticular indwelling

    vacuum drainage is indwelled in intraarticular space

    Also known as: hemovac

06

What researchers measure

Primary outcomes

  1. blood parameters by which we can estimate blood loss , such as drained blood volume, hemoglobin and hemoglobin drop

    Time frame: 24 hours after operation

Secondary outcomes

  1. transfusion

    Time frame: during hospital stay

  2. wound problem

    Time frame: during hospital stay

  3. hypotension episode

    Time frame: during hospital stay

  4. functional outcome (ROM, AKS Knee score, WOMAC score, SF-36 score)

    Time frame: preoperative & postoperative 1 year

07

Study locations

1 site
  • Joint Reconstruction Center, Seoul National University Bundang Hospital
    Seongnam-si, Gyeonggi-do 463-707, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 9, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00916331
Lead sponsor
Seoul National University Hospital
First posted
Jun 9, 2009
Start date
May 2006
Primary completion
Jun 2007
Completion
Jun 2007
Last update
Jun 9, 2009

Study contacts

Tae Kyun Kim, MD, PhD
principal investigator · Joint Recontruction Center, Seoul National University Bundang hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion